Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers

被引:24
作者
Bárány, P
Stenvinkel, B
Ottosson-Seeberger, A
Alvestrand, A
Morrow, J
Roberts, JJ
Salahudeen, AK
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Dept Clin Sci, Div Renal Med, Stockholm, Sweden
[2] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA
[3] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA
关键词
cyclosporin A; glomerular filtration rate; renal plasma flow; vitamin E; tocopherol;
D O I
10.1093/ndt/16.3.580
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. A single oral dose of cyclosporin-A (CsA) transiently reduces renal plasma flow (RPF) and glomerular filtration rate (GFR) in transplant patients and, in some patients, chronic administration of CsA leads to renal impairment and fibrosis. Based on experimental studies, several mediators including free radicals have been proposed to account for CsA-nephrotoxicity. We have previously reported that administration of the antioxidant vitamin E in a rat model of chronic CsA-nephrotoxicity reduces renal fibrosis and maintains renal function. Methods. In the present study, the effect on renal haemodynamics of a single dose of the new oral formulation of CsA (neoral) was assessed before and after 6 weeks of vitamin E (800 IU/day, 2-fold increase in serum vitamin E). GFR (inulin clearance) and RPF (para-amino hippuric acid clearance) were measured before and after a single dose of 5 mg/kg of neoral in 12 healthy subjects under standardised conditions. Results. Although the mean area under the curve of the CsA levels was 21% lower after the vitamin E period, the peak CsA level at 120 min after neoral was similar both before and after vitamin E administration. At 120 min after neoral, a transient reduction in RPF and GFR was noted both before and after vitamin E administration. The nadir of the reductions in RPF (-81+/-27 ml/min) and GFR (-14+/-6 ml/min) at 120 min compared with baseline tended to be lower before than after the treatment with vitamin E (-51+/-33 ml/min of RPF and -12+/-8, ml/min of GFR, respectively). Plasma and urine levels of F2-isoprostanes (free radical-catalysed vasoconstrictive prostanoids (F2-iso) at 120 min after the administration of neoral were not different from the pre-neoral levels. Conclusion. The findings demonstrate that a single oral dose of neoral causes transient, yet significant, reductions in RPF and GFR, and suggest that F2-iso might not be involved in the CsA-induced acute renal vasoconstriction. The tendency for a lower reduction in RPF and GFR following CsA during the vitamin E period in healthy humans warrants additional studies in transplant patients.
引用
收藏
页码:580 / 584
页数:5
相关论文
共 21 条
[11]  
Morrow JD, 1999, METHOD ENZYMOL, V300, P3
[12]   A SERIES OF PROSTAGLANDIN-F2-LIKE COMPOUNDS ARE PRODUCED INVIVO IN HUMANS BY A NONCYCLOOXYGENASE, FREE RADICAL-CATALYZED MECHANISM [J].
MORROW, JD ;
HILL, KE ;
BURK, RF ;
NAMMOUR, TM ;
BADR, KF ;
ROBERTS, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) :9383-9387
[13]   Cyclosporine a nephrotoxicity: Role of thromboxane and reactive oxygen species [J].
Parra, T ;
de Arriba, G ;
Arribas, I ;
de Lema, GP ;
Rodriguez-Puyol, D ;
Rodriguez-Puyol, M .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 131 (01) :63-70
[14]   DAILY RENAL HYPOPERFUSION INDUCED BY CYCLOSPORINE IN PATIENTS WITH RENAL-TRANSPLANTATION [J].
PERICO, N ;
RUGGENENTI, P ;
GASPARI, F ;
MOSCONI, L ;
BENIGNI, A ;
AMUCHASTEGUI, CS ;
GASPARINI, F ;
REMUZZI, G .
TRANSPLANTATION, 1992, 54 (01) :56-60
[15]  
Salahudeen AK, 1999, FASEB J, V13, pA808
[16]   Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy [J].
Shihab, FS ;
Andoh, TF ;
Tanner, AM ;
Noble, NA ;
Border, WA ;
Franceschini, N ;
Bennett, WM .
KIDNEY INTERNATIONAL, 1996, 49 (04) :1141-1151
[17]   GLOMERULAR ACTIONS OF A FREE RADICAL-GENERATED NOVEL PROSTAGLANDIN, 8-EPI-PROSTAGLANDIN-F2-ALPHA, IN THE RAT - EVIDENCE FOR INTERACTION WITH THROMBOXANE-A2 RECEPTORS [J].
TAKAHASHI, K ;
NAMMOUR, TM ;
FUKUNAGA, M ;
EBERT, J ;
MORROW, JD ;
ROBERTS, LJ ;
HOOVER, RL ;
BADR, KF .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :136-141
[18]  
*UNOS, 1999, UNOS SCI REG DAT
[19]   Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension [J].
Vaziri, ND ;
Ni, ZM ;
Zhang, YP ;
Ruzics, EP ;
Maleki, P ;
Ding, YX .
KIDNEY INTERNATIONAL, 1998, 54 (02) :482-491
[20]   LIPID-PEROXIDATION ACCOMPANIES CYCLOSPORINE NEPHROTOXICITY - EFFECTS OF VITAMIN-E [J].
WANG, CY ;
SALAHUDEEN, AK .
KIDNEY INTERNATIONAL, 1995, 47 (03) :927-934